Company intelligence / Profile preview

weCANdev Consulting Group

Toronto, Ontario, Canadaca.linkedin.com ↗

Ownership: Private
Development stage: Other

Overview

weCANdev Consulting Group specializes in advancing cell and gene therapy technologies by providing expert product development teams focused on partner value creation from concept to market. They design scalable manufacturing processes and phase/stage appropriate analytics for R&D and clinical-stage cell therapies[1][2][3].

The company has its own laboratory facilities to support process and analytical development for cell therapies[2].
Their expertise includes iPSC derivation, genome engineering, preclinical process development, and analytical method development[5].
No direct clinical results as they are a consulting/service provider.

Modalities: Cell therapyGene therapy
Industry: Drug Discovery Services

Partnerships

Partner of the weCANtranslate Network

Beyond the preview

Go deeper on weCANdev Consulting Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on weCANdev Consulting Group.

Explore the full profile